학술논문

FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy
Document Type
Article
Source
In: Frontiers in Oncology. (Frontiers in Oncology, 2023, 13)
Subject
Language
English
ISSN
2234943X